The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.
The Federal Trade Commission reached a landmark settlement with Express Scripts, banning the pharmacy benefit manager from favoring high-priced drugs to secure larger rebates. The agreement mandates ...
Hosted on MSN
How Express Scripts is changing drug pricing
Express Scripts, part of Cigna’s Evernorth, is overhauling its pharmacy benefits model to lower out-of-pocket costs and boost transparency. Initiatives include capped copays, passing negotiated ...
The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The dispute centers on ...
Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and demanded the agency retract a report saying the industry middlemen ...
The Federal Trade Commission reached a settlement with Cigna’s Express Scripts in a case over alleged inflation of insulin prices, according to a Feb. 4 agency news release. With the move, the FTC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results